Krystal Biotech Inc (KRYS)
182.29
+4.19
(+2.35%)
USD |
NASDAQ |
Nov 21, 16:00
182.47
+0.18
(+0.10%)
After-Hours: 20:00
Krystal Biotech Revenue (Quarterly): 83.84M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 83.84M |
June 30, 2024 | 70.28M |
March 31, 2024 | 45.25M |
Date | Value |
---|---|
December 31, 2023 | 42.14M |
September 30, 2023 | 8.556M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
8.556M
Minimum
Sep 2023
83.84M
Maximum
Sep 2024
50.01M
Average
45.25M
Median
Mar 2024
Revenue (Quarterly) Benchmarks
Bioventus Inc | 138.96M |
ADMA Biologics Inc | 119.84M |
Alnylam Pharmaceuticals Inc | 500.92M |
Amicus Therapeutics Inc | 141.52M |
Rhythm Pharmaceuticals Inc | 33.25M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | 27.18M |
Total Expenses (Quarterly) | 48.91M |
EPS Diluted (Quarterly) | 0.91 |
Enterprise Value | 4.654B |
Gross Profit Margin (Quarterly) | 92.03% |
Profit Margin (Quarterly) | 32.42% |
Earnings Yield | 0.98% |
Operating Earnings Yield | 1.21% |
Normalized Earnings Yield | 1.595 |